Naomi Fried

Naomi Fried, Ph.D., is the founder and CEO of PharmStars, the pharma-focused accelerator for digital health startups and a GP at PharmStars Ventures. Startups with digital innovations for pharma can apply to PharmStars’ Spring cohort until January 25, 2026. Previously, Naomi was VP of Innovation at Biogen, Chief Innovation Officer at Boston Children’s Hospital, and VP of Innovation & Advanced Technology at Kaiser Permanente.

Posts by Naomi Fried

MedCity Influencers

Digital Innovation in Pharma: What Will 2026 Bring?

This year will be the turning point from AI “hype” to the adoption of meaningful AI and digital health solutions in pharma. Here four predictions.

MedCity Influencers

Challenges and Opportunities for Digital Innovation in Clinical Trials

The clinical trial process is complex, long, and always arduous. But the results of the drug development process can be amazing, new, safe, effective, life-changing, and life-enhancing therapies.

The Hidden Administrative Tasks Draining Small Practices

Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.

MedCity Influencers

The Opportunity for Digital Innovation in Oncology Drug Development

Solving three major challenges in the development of new oncology drugs

Naomi Fried

Posts by Naomi Fried

Digital Innovation in Pharma: What Will 2026 Bring?

Challenges and Opportunities for Digital Innovation in Clinical Trials

The Hidden Administrative Tasks Draining Small Practices

The Opportunity for Digital Innovation in Oncology Drug Development

Behavioral Health Demand Has Increased by 62% Since 2018. What the Industry Needs to Know

Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs

Your Doctors and Nurses Are Burned Out. Here’s What They Need